Google Finance: notícies i preu del fons d'inversió Fidelity Advisor Biotechnology Fund

Pàgina d'iniciFIJYX • Fons d'inversió

Fidelity Advisor Biotechnology Fund - Class Z

28,79 $

30 de juny · USD · MUTF · Exempció de responsabilitat

Fidelity Advisor Biotechnology Fund - Class C

20,15 $

FBTCX0,050 %

Fidelity Advisor Biotechnology Fund - Class M

23,73 $

FBTTX0,084 %

Fidelity Advisor Biotechnology Fund - Class A

26,12 $

FBTAX0,077 %

Fidelity Advisor Biotechnology Fund - Class I

28,72 $

FBTIX0,070 %

BlackRock Health Sciences Opportunities Portfolio Service Shares

61,74 $

SHISX0,13 %

BlackRock Health Sciences Opportunities Portfolio Institutional Shares

66,20 $

SHSSX0,12 %

Fidelity Select Pharmaceuticals Portfolio

24,56 $

FPHAX0,081 %

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

61,39 $

SHSAX0,11 %

Fons d'inversió

Tancament anterior

28,77 $

Ingressos d'enguany

-7,18 %

Proporció de despeses

0,58 %

Categoria

Healthcare Sector Equity

Classificació de Morningstar

Actius nets

59,88 M USD

Rendibilitat

3,18 %

Avançament

Data de creació

2 d’oct. 2018

Notícies dels mercats

Barron's

fa 11 hores

Wall Street Analysts Have Given the Most Buy Ratings Since 2022. It’s a Sign.

Stock market today: Dow, S&P 500, Nasdaq rise as momentum builds for Trump trade deals, tax bill

Home Depot heads deeper into the building supply business with $5 billion acquisition of GMS

0,57 %

GMS

11,73 %

Investor's Business Daily

fa 14 hores

Goldman Sachs And These Banks Just Aced The Fed's Stress Test: Analyst

2,45 %

AOL.com

fa 8 hores

Prediction: These Will Be the Two Best-Performing "Magnificent Seven" Stocks Over the Next 5 Years

Todd Boehly-backed Accelerant files for NYSE listing as IPO market gathers steam